Credit: Komsan Loonprom/Shutterstock. Astellas Pharma and Sangamo Therapeutics have signed a licence agreement for a neurotropic adeno-associated virus (AAV) capsid, STAC-BBB, aimed at treating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback